GRDN
Guardian Pharmacy Services, Inc. NYSE Listed Apr 21, 2016$42.41
-2.28%
vs $43.40
Mkt Cap $2.7B
52w Low $19.68
95.8% of range
52w High $43.40
50d MA $38.49
200d MA $32.35
P/E (TTM)
50.6x
EV/EBITDA
25.6x
P/B
12.1x
Debt/Equity
0.2x
ROE
23.8%
P/FCF
33.3x
RSI (14)
72.10
ATR (14)
$1.57
Beta
0.47
50d MA
$38.49
200d MA
$32.35
Avg Volume
427.1K
Guardian Pharmacy Services, Inc., a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes. The company's Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; and GuardianShield Programs for LTCFs. The company was founded in 2003 and is based in Atlanta, Georgia.
300 Galleria Parkway SE · Atlanta, GA 30339 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 6, 2026 | AMC | 0.24 | 0.29 | +20.8% | 36.58 | -3.4% | -0.8% | -0.5% | -1.2% | -2.1% | +2.2% | — |
| Mar 11, 2026 | AMC | 0.27 | 0.37 | +37.0% | 33.51 | +3.0% | -0.7% | -2.0% | +1.0% | +3.5% | -0.5% | — |
| Nov 10, 2025 | AMC | 0.24 | 0.25 | +4.2% | 29.75 | +7.3% | +5.0% | +1.0% | -3.6% | -4.0% | -3.0% | — |
| Aug 11, 2025 | AMC | 0.22 | 0.23 | +4.5% | 19.88 | +3.1% | +13.8% | +4.1% | +1.4% | -1.1% | +5.1% | — |
| May 12, 2025 | AMC | 0.22 | 0.21 | -4.5% | 25.66 | -1.0% | -4.0% | -2.1% | +3.3% | -0.9% | +7.4% | — |
| Mar 26, 2025 | AMC | 0.21 | 0.24 | +14.3% | 20.23 | -3.6% | +4.3% | -4.5% | +5.5% | -1.2% | +2.5% | — |
| Nov 12, 2024 | AMC | 0.19 | -2.00 | -1152.6% | 22.18 | -12.8% | -10.7% | +6.1% | -0.3% | +2.2% | +0.8% | — |
| Sep 26, 2024 | AMC | — | 0.17 | — | 16.00 | +3.1% | +10.9% | -5.4% | +2.9% | +0.5% | -2.4% | — |
| Aug 22, 2024 | AMC | — | 0.24 | — | — | — | — | — | — | — | — | — |
| Dec 31, 2023 | AMC | — | 0.10 | — | — | — | — | — | — | — | — | — |
| Sep 30, 2023 | AMC | — | -0.19 | — | — | — | — | — | — | — | — | — |
| Jun 30, 2023 | AMC | — | 0.35 | — | — | — | — | — | — | — | — | — |
| Mar 31, 2023 | AMC | — | 0.03 | — | — | — | — | — | — | — | — | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 27 | BofA Securities | Initiates | Buy | $42 | $37.57 | $38.15 | +1.5% | +1.0% | -0.9% | -0.1% | -1.3% | +0.7% |
| Apr 13 | Truist | Maintains | Buy → Buy | — | $39.15 | $39.13 | -0.1% | +0.9% | -4.3% | -1.9% | -0.4% | +1.6% |
| Mar 12 | Oppenheimer | Maintains | Outperform → Outperform | — | $33.51 | $34.52 | +3.0% | -0.7% | -2.0% | +1.0% | +3.5% | -0.5% |
| Mar 12 | Truist | Maintains | Buy → Buy | — | $33.51 | $34.52 | +3.0% | -0.7% | -2.0% | +1.0% | +3.5% | -0.5% |
| Jan 14 | Stephens & Co. | Maintains | Overweight → Overweight | — | $31.26 | $31.81 | +1.8% | -3.6% | -2.1% | -8.4% | +4.8% | +3.6% |
| Nov 14 | Truist | Maintains | Buy → Buy | — | $30.42 | $30.52 | +0.3% | -4.0% | -3.0% | -1.5% | -1.3% | +0.3% |
| Sep 26 | Truist | Maintains | Buy → Buy | — | $25.45 | $25.60 | +0.6% | +2.2% | +0.2% | +0.6% | -7.2% | +0.3% |
| May 19 | Truist | Maintains | Buy → Buy | — | $24.69 | $24.79 | +0.4% | +7.4% | -0.1% | -16.8% | +2.4% | -2.8% |
| Apr 11 | Truist | Maintains | Buy → Buy | — | $21.76 | $22.07 | +1.4% | +5.1% | +0.1% | +1.9% | +0.9% | +2.5% |
| Nov 15 | Truist | Maintains | Buy → Buy | — | $21.00 | $21.17 | +0.8% | -0.3% | +2.2% | +0.8% | -1.3% | +3.8% |
No insider trades available.
8-K · 1.01
!! High
Guardian Pharmacy Services, Inc. -- 8-K 1.01: Material Agreement
Guardian Pharmacy Services amended a material agreement, with full details available in the attached exhibit, though the specific terms and financial impact remain unclear from this disclosure alone.
May 28
8-K
Unknown — 8-K Filing
Garden Inc. has secured investor commitments through stock purchase agreements expiring June 30, 2026 or 180 days after a public offering, providing near-term capital flexibility but potential dilution depending on exercise timing.
Mar 23
8-K
Unknown — 8-K Filing
Guardian Pharmacy Services raised 2026 EBITDA guidance, signaling management confidence in operational improvements and sustained growth that should support stock appreciation.
Mar 11
Institutional (13F) — Top 20
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Fmr Llc | 2,359,357 | $89M | Added | Mar 2026 |
| 2 | Woodline Partners Lp | 1,306,318 | $49M | Added | Mar 2026 |
| 3 | Vanguard Capital Management Llc | 1,225,543 | $46M | New | Mar 2026 |
| 4 | Valiant Capital Management, L.p. | 1,186,658 | $45M | Reduced | Mar 2026 |
| 5 | Boston Partners | 1,017,683 | $38M | Reduced | Mar 2026 |
| 6 | Franklin Resources Inc | 952,952 | $36M | Reduced | Mar 2026 |
| 7 | Citadel Advisors Llc | 579,121 | $22M | New | Mar 2026 |
| 8 | Nuveen, Llc | 537,451 | $20M | Reduced | Mar 2026 |
| 9 | Marshall Wace, Llp | 417,710 | $16M | New | Mar 2026 |
| 10 | Sei Investments Co | 358,181 | $13M | Added | Mar 2026 |
| 11 | Two Sigma Investments, Lp | 312,675 | $12M | Added | Mar 2026 |
| 12 | Alyeska Investment Group, L.p. | 275,000 | $10M | New | Mar 2026 |
| 13 | Raymond James Financial Inc | 261,019 | $10M | New | Mar 2026 |
| 14 | Vanguard Portfolio Management Llc | 248,513 | $9M | New | Mar 2026 |
| 15 | Morgan Stanley | 292,502 | $9M | Reduced | Dec 2025 |
| 16 | Clearbridge Investments, Llc | 202,815 | $8M | Reduced | Mar 2026 |
| 17 | Peregrine Capital Management Llc | 201,603 | $8M | Reduced | Mar 2026 |
| 18 | Acadian Asset Management Llc | 195,072 | $7M | Added | Mar 2026 |
| 19 | Northern Trust Corp | 189,249 | $7M | Reduced | Mar 2026 |
| 20 | Allspring Global Investments Holdings, Llc | 136,012 | $5M | Reduced | Mar 2026 |
Mutual Funds / ETFs (N-PORT) — Top 20
All ↗
Valuation
Market Cap
$2.68B
Enterprise Value
$2.62B
P/E (TTM)
50.59x
Forward P/E
34.65x
PEG Ratio
-0.26x
P/B
12.14x
P/S
1.84x
P/FCF
33.26x
EV/EBITDA
25.60x
Shares Out
63.3M
Financials (TTM)
Revenue
$1.46B
Net Income
$53.1M
EBITDA
$102.3M
Free Cash Flow
$80.7M
Op Cash Flow
$100.3M
EPS Basic
$0.79
EPS Diluted
$0.83
EPS Forward
$1.22
Gross Margin
20.9%
Op Margin
5.8%
Net Margin
3.6%
Balance Sheet
Total Assets
$412.7M
Total Liab.
$194.7M
Total Equity
$217.9M
Cash
$65.6M
LT Debt
$0
Book Value/Sh
$3.49
Debt/Equity
0.22x
Current Ratio
1.38
Quick Ratio
1.11
Returns & Growth
ROE
23.8%
ROA
11.9%
ROIC
22.3%
Rev Growth YoY
+17.9%
EPS Growth YoY
+144.6%
Price Returns
2W
+6.8%
1M
+4.4%
3M
+15.6%
6M
+32.3%
12M
+83.0%
Technicals
52W High
$43.40
52W Low
$19.68
50d MA
$38.49
200d MA
$32.35
RSI (14)
72.10
ATR (14)
$1.57
Beta
0.47
Avg Volume
427K
Dividends
Div Rate
$0.00
Div Yield
—
Frequency
—
Ex-Div Date
—
Analyst Price Targets
Consensus
$38.00
High
$40.00
Low
$36.00
Median
$38.00
Data updated apr 25, 2026 12:16pm
· Source: financialmodelingprep.com